BURLESON GENE E 4
4 · SUNLINK HEALTH SYSTEMS INC · Filed Oct 23, 2023
Insider Transaction Report
Form 4
BURLESON GENE E
Director
Transactions
- Disposition to Issuer
Series C Fractional Interests
2023-10-19−81,601→ 0 total - Disposition to Issuer
Series C Fractional Interests
2023-10-19−10,000→ 0 total(indirect: By Trust)
Holdings
- 10,000(indirect: By Trust)
Common Stock
- 81,601
Common Stock
Footnotes (3)
- [F1]This Form 4 relates to the automatic redemption of all Series C Fractional Interests for no consideration following shareholder approval of the Issuer's Reincorporation Proposal at a special meeting held on October 19, 2023.
- [F2]This row reflects direct ownership which has not changed as a result of the transactions reported on this form.
- [F3]This row reflects indirect ownership which has not changed as a result of the transactions reported on this form.